Filtered By:
Countries: Argentina Health

This page shows you your search results in order of date. This is page number 5.

Order by Relevance | Date

Total 71 results found since Jan 2013.

Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina
Abstract Apixaban, a novel oral anticoagulant which has been approved for the prevention of stroke and systemic embolism in non-valvular atrial fibrillation, reduces both ischemic and haemorrhagic stroke and produces fewer bleedings than vitamin K antagonist warfarin. These clinical results lead to a decrease in health care resource utilization and, therefore, have a positive impact on health economics of atrial fibrillation. The cost-effectiveness of apixaban has been assessed in a variety of clinical settings and countries. However, data from emergent markets, as is the case of Argentina, are still scarce. ...
Source: Health Economics Review - June 26, 2015 Category: Global & Universal Source Type: research

Challenges and Opportunities for Implementation of Interventions to Prevent and Control CVD in Low-Resource Settings A Report From CESCAS in Argentina
Publication date: March 2015 Source:Global Heart, Volume 10, Issue 1 Author(s): Adolfo L. Rubinstein , Vilma E. Irazola , Rosana Poggio , Pablo Gulayin , Analía Nejamis , Andrea Beratarrechea In Argentina, cardiovascular diseases cause an estimated 100,000 deaths and more than 250,000 coronary heart disease and stroke events annually, at a cost of more than $1 billion international dollars. Despite progress in the implementation of several programs to combat noncommunicable diseases in Argentina over the past few years, most health resources are still dedicated to infectious diseases and maternal and child health. The I...
Source: Global Heart - April 13, 2015 Category: Cardiology Source Type: research

Identifying Barriers in Acute Stroke Therapy in Argentina. ARENAS Registry (P2.014)
CONCLUSIONS: Only 47% of patients were admitted to an Intensive Care Unit, rt-PA was underused and initial evaluation was not performed by a neurologist in most of cases. The gap between clinical practice guidelines and real world is wide in Argentina and interventions to improve acute stroke care are mandatory.Disclosure: Dr. Atallah has nothing to disclose. Dr. Fustinoni has nothing to disclose. Dr. Zurru has nothing to disclose. Dr. Beigelman has nothing to disclose. Dr. Cirio has nothing to disclose. Dr. Ameriso has nothing to disclose. Dr. Burry has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Atallah, A., Fustinoni, O., Zurru, M., Beigelman, R., Cirio, J., Ameriso, S., Burry, G. Tags: Cerebrovascular Disease and Interventional Neurology I Source Type: research

Perception Of Stroke Symptoms And Utilization Of Emergency Medical Systems In Argentina (P7.132)
CONCLUSIONS:These results suggest a low level of stroke symptoms awareness in our country even in a population of middle/high socioeconomic level. The role and procedures of EMS in Argentina should be revised as early arrival and treatment appear to be associated with no utilization of them.Study Supported by:Disclosure: Dr. Hawkes has nothing to disclose. Dr. Calandri has nothing to disclose. Dr. Farez has received personal compensation for activities with Merck Serono. Dr. Farez has received research support from Novartis. Dr. Arena has nothing to disclose. Dr. Pujol Lereis has nothing to disclose. Dr. Ameriso has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Hawkes, M., Calandri, I., Farez, M., Arena, J., Pujol Lereis, V., Ameriso, S. Tags: Cerebrovascular Disease and Interventional Neurology: Barriers and Opportunities in Acute Stroke Treatment Source Type: research

Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopthy (CADASIL) in Argentina (P2.123)
ConclusionsTo the best of our knowledge, this is the first cases series of patients with CADASIL in Argentina. Our findings are similar to those reported in the literature for other regions.Study Supported by:Disclosure: Dr. Hawkes has nothing to disclose. Dr. Wilken has nothing to disclose. Dr. Bruno has nothing to disclose. Dr. Pujol Lereis has nothing to disclose. Dr. Povedano has nothing to disclose. Dr. Taratuto has nothing to disclose. Dr. Taratuto has nothing to disclose. Dr. Ameriso has nothing to disclose.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Hawkes, M., Wilken, M., Bruno, V., Pujol Lereis, V., Povedano, G., Lubieniecki, F., Taratuto, A. L., Ameriso, S. Tags: Cerebrovascular Disease and Interventional Neurology: Behavioral, Cognitive, and Miscellaneous Source Type: research

Impact on cardiovascular disease events of the implementation of Argentina's national tobacco control law
Conclusions Implementation of the tobacco control law would produce significant public health benefits in Argentina. Strong advocacy is needed at national and international levels to get this law implemented throughout Argentina.
Source: Tobacco Control - February 11, 2014 Category: Respiratory Medicine Authors: Konfino, J., Ferrante, D., Mejia, R., Coxson, P., Moran, A., Goldman, L., Perez-Stable, E. J. Tags: Online article Source Type: research

Program for the epidemiological evaluation of stroke in Tandil, Argentina (PREVISTA) study: rationale and design
The availability of population‐based epidemiological data on the incident risk of stroke is very scarce in Argentina and other Latin American countries. In response to the priorities established by the World Health Organization and the United Nations, PREVISTA was envisaged as a population‐based program to determine the risk of first‐ever and recurrent stroke and transient ischemic attack incidence and mortality in Tandil, Buenos Aires, Argentina. The study will be conducted according to Standardized Tools for Stroke Surveillance (STEPS Stroke) methodology and will enroll all new (incident) and recurrent consecutive ...
Source: International Journal of Stroke - September 11, 2013 Category: Neurology Authors: Luciano A. Sposato, Mariano L. Coppola, Juan Altamirano, Brenda Borrego Guerrero, Jorge Casanova, Maximiliano De Martino, Alejandro Díaz, Valery L. Feigin, Fernando Funaro, María E. Gradillone, María L. Lewin, Renato D. Lopes, Daniel H. López, Mariel Tags: Protocol Source Type: research

Background of the Sociedad Neurologica Argentina: Current state and concerns about neurologic education
Neurology in Argentina emerged toward the end of the 19th century, following the origin of the specialty in Europe. Its development can be divided into 3 periods. The first is the specialty of neurology as part of internal medicine. Doctoral theses and publication about neurologic topics are found early in the history of medicine, but merged into internal medicine. The second period is the foundation of clinical neurology under the typical European influence, mainly French, when the first neurologists appear. This period started in 1885 with the creation of the Hospital San Roque de Buenos Aires' first nervous diseases dep...
Source: Neurology - May 20, 2013 Category: Neurology Authors: Correale, J., Allegri, R. F., Pelli-Noble, R. F. Tags: History of Neurology, CME, Methods of education GLOBAL PERSPECTIVES Source Type: research

AISYF: Argentinean Initiative of Stroke in the Young and Fabry Disease (FD) (P02.038)
CONCLUSIONS: Although FD was not yet identified in our cohort its early recognition in young patients with stroke is essential for appropiate treatment. Despite extensive investigations stroke of undetermined etiology remains a frequent challenge in young patients.Supported by: Shire HGT.Disclosure: Dr. Reisin has received personal compensation for activities with Shire Pharmaceuticals Company as a consultant. Dr. Reisin has received personal compensation in an editorial capacity for Gador. Dr. Reisin has received research support from Shire Pharmaceuticals Company.
Source: Neurology - February 14, 2013 Category: Neurology Authors: Reisin on Behalf of the AISYF Research Group, R. Tags: P02 Cerebrovascular Disease II Source Type: research

Seasonal Variation and Trends in Stroke Hospitalizations and Mortality in a South American Community Hospital
Numerous studies have reported the presence of temporal variations in biological processes. Seasonal variation (SV) in stroke has been widely studied, but little data have been published on this phenomenon in the Southern Hemisphere, and there have been no studies reported from Argentina. The goals of the present study were to describe the SV of admissions and deaths for stroke and examine trends in stroke morbidity and mortality over a 3-year period in a community hospital in Argentina. Hospital discharge reports from the electronic database of vital statistics between 1999 and 2001 were examined retrospectively. Patients...
Source: Journal of Stroke and Cerebrovascular Diseases - May 21, 2012 Category: Neurology Authors: Alejandro Díaz, Eliana Roldan Gerschcovich, Adriana A. Díaz, Fabiana Antía, Sergio Gonorazky Tags: Original Articles Source Type: research